A Consideration of Fixed Dosing Versus Body Size-Based Dosing Strategies for Chimeric Antigen Receptor T-Cell Therapies.
He JZ, Wang H, Lim K, Ren S, Rollins F, Vallaster M, Wong R, Stebbings R, Standifer N, Keefe R, Phipps A, Gibbs M.
He JZ, et al. Among authors: phipps a.
Clin Pharmacol Drug Dev. 2022 Oct;11(10):1130-1135. doi: 10.1002/cpdd.1171. Epub 2022 Sep 12.
Clin Pharmacol Drug Dev. 2022.
PMID: 36094760
Free PMC article.
No abstract available.